EN
HI
Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
14.24 L
Market Cap
11607.36 CR
LTQ@LTP
50@256.07
ATP
257.52
Var Margin
21.88 %
Circuit Range
210.42-315.62
Delivery %
30.2 %
Value
36.66 CR
ASM/GSM
No
Market Lot
1
Summary
Marksans Pharma share price is ₹256.07 as of 25 Jun, 2026. The stock Marksans Pharma intraday movement has stayed between ₹253.60 and ₹265.85, while on a 52-week basis,Marksans Pharma price 52 week high is ₹275.50 & its 52 week low is ₹155.00.
In terms of trading activity, Marksans Pharma has recorded a volume of 1423556 shares, The Marksans Pharma has a market cap of ₹453288438 CR. The stock’s Average Traded Price (ATP) stands at ₹257.52, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹256.07.
Marksans Pharma operates within a circuit range of ₹210.42 – ₹315.62, with a Value of ₹36.66 CR. The Delivery Percentage for the day is 30.2%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
P/E Ratio
28.56
P/B Ratio
3.95
Div. Yield
0.34
Sector P/E
70.05
Sector P/B
3.14
Sec. Div. Yield
0.53
Marksans Pharma Resistance and Support
Pivot 266.54
Resistance
First Resistance
271.98
Second Resistance
280.94
Third Resistance
286.38
Support
First Support
257.58
Second Support
252.14
Third Support
243.18
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Announcement Under Regulation 30 (LODR)- Updates
Marksans Pharma announced the completion of its 100% acquisition of QliniQ B.V., a company located in the Netherlands. This acquisition finalizes the process previously intimated on June 1st, 2026.
Jun 16 2026 14:48:28
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Credit Rating
Marksans Pharma received an upgraded outlook for its Rs.195.75 crore bank loan facilities from Stable to Positive by India Ratings. The ratings were affirmed at IND AA-/IND A1+.
Jun 09 2026 15:12:43
Read More
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Concord Biotech Ltd.
1286.10
-4.90 (0.38%)
Vijaya Diagnostic Centre Ltd.
1367.80
55.20 (4.21%)
Alivus Life Sciences Ltd.
1108.30
-7.80 (0.70%)
Park Medi World Ltd.
285.50
-2.10 (0.73%)
CORONA Remedies Ltd.
1893.30
-55.30 (2.84%)
Viyash Scientific Ltd.
269.30
-1.95 (0.72%)
Shilpa Medicare Ltd.
571.60
-8.05 (1.39%)
Sanofi Consumer Healthcare India Ltd.
4618.10
-67.20 (1.43%)
Metropolis Healthcare Ltd.
543.35
-9.85 (1.78%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 256.07 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 28.56. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 3.95. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 70.05 & 3.14 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 11607.36 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 275.50 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
